WESCO International, Inc. (WCC)
NYSE: WCC · Real-Time Price · USD
209.07
+5.58 (2.74%)
Aug 4, 2025, 4:00 PM - Market closed
Sage Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 22,232 | 21,819 | 22,385 | 21,420 | 18,218 | 12,326 | Upgrade | |
Revenue Growth (YoY) | 1.30% | -2.53% | 4.51% | 17.58% | 47.80% | 47.46% | Upgrade |
Cost of Revenue | 17,487 | 17,106 | 17,542 | 16,759 | 14,425 | 9,955 | Upgrade |
Gross Profit | 4,745 | 4,713 | 4,844 | 4,661 | 3,792 | 2,371 | Upgrade |
Selling, General & Admin | 3,323 | 3,254 | 3,189 | 3,031 | 2,617 | 1,719 | Upgrade |
Operating Expenses | 3,511 | 3,437 | 3,368 | 3,210 | 2,815 | 1,840 | Upgrade |
Operating Income | 1,234 | 1,275 | 1,475 | 1,451 | 977 | 531.22 | Upgrade |
Interest Expense | -350.9 | -364.9 | -389.3 | -294.4 | -268.1 | -226.59 | Upgrade |
Currency Exchange Gain (Loss) | -2.9 | -25.5 | -22.9 | - | - | -4.9 | Upgrade |
Other Non Operating Income (Expenses) | 2.3 | 2.2 | 2.6 | -20 | -5.1 | -0.95 | Upgrade |
EBT Excluding Unusual Items | 882.2 | 887 | 1,066 | 1,137 | 703.8 | 298.77 | Upgrade |
Merger & Restructuring Charges | -29.6 | -37 | -72.1 | - | -158.5 | -175.93 | Upgrade |
Gain (Loss) on Sale of Assets | 19.3 | 122.2 | - | - | - | - | Upgrade |
Asset Writedown | - | -17.8 | -1.6 | - | - | - | Upgrade |
Other Unusual Items | 2.5 | -3.4 | - | - | 36.6 | - | Upgrade |
Pretax Income | 874.4 | 951 | 992 | 1,137 | 581.9 | 122.84 | Upgrade |
Income Tax Expense | 210.8 | 231.6 | 225.9 | 274.5 | 115.5 | 22.8 | Upgrade |
Earnings From Continuing Operations | 663.6 | 719.4 | 766.1 | 862.2 | 466.4 | 100.04 | Upgrade |
Minority Interest in Earnings | -1 | -1.8 | -0.6 | -1.7 | -1 | 0.52 | Upgrade |
Net Income | 662.6 | 717.6 | 765.5 | 860.5 | 465.4 | 100.56 | Upgrade |
Preferred Dividends & Other Adjustments | 28.4 | 57.4 | 57.4 | 57.4 | 57.4 | 30.14 | Upgrade |
Net Income to Common | 634.2 | 660.2 | 708.1 | 803.1 | 408 | 70.42 | Upgrade |
Net Income Growth | -8.38% | -6.26% | -11.04% | 84.89% | 362.81% | -54.99% | Upgrade |
Shares Outstanding (Basic) | 49 | 50 | 51 | 51 | 50 | 46 | Upgrade |
Shares Outstanding (Diluted) | 50 | 51 | 52 | 52 | 52 | 47 | Upgrade |
Shares Change (YoY) | -3.96% | -3.25% | -0.19% | 0.77% | 11.53% | 7.22% | Upgrade |
EPS (Basic) | 12.96 | 13.26 | 13.86 | 15.84 | 8.11 | 1.53 | Upgrade |
EPS (Diluted) | 12.76 | 13.05 | 13.54 | 15.33 | 7.84 | 1.51 | Upgrade |
EPS Growth | -0.78% | -3.62% | -11.68% | 95.54% | 419.20% | -70.62% | Upgrade |
Free Cash Flow | 618.8 | 1,007 | 400.9 | -88.4 | 12.4 | 487.26 | Upgrade |
Free Cash Flow Per Share | 12.45 | 19.89 | 7.67 | -1.69 | 0.24 | 10.45 | Upgrade |
Dividend Per Share | 1.732 | 1.650 | 1.500 | - | - | - | Upgrade |
Dividend Growth | 9.87% | 10.00% | - | - | - | - | Upgrade |
Gross Margin | 21.34% | 21.60% | 21.64% | 21.76% | 20.82% | 19.24% | Upgrade |
Operating Margin | 5.55% | 5.85% | 6.59% | 6.77% | 5.36% | 4.31% | Upgrade |
Profit Margin | 2.85% | 3.03% | 3.16% | 3.75% | 2.24% | 0.57% | Upgrade |
Free Cash Flow Margin | 2.78% | 4.61% | 1.79% | -0.41% | 0.07% | 3.95% | Upgrade |
EBITDA | 1,392 | 1,428 | 1,619 | 1,592 | 1,148 | 638.52 | Upgrade |
EBITDA Margin | 6.26% | 6.54% | 7.23% | 7.43% | 6.30% | 5.18% | Upgrade |
D&A For EBITDA | 158 | 152.9 | 143.3 | 140.7 | 171.1 | 107.3 | Upgrade |
EBIT | 1,234 | 1,275 | 1,475 | 1,451 | 977 | 531.22 | Upgrade |
EBIT Margin | 5.55% | 5.85% | 6.59% | 6.77% | 5.36% | 4.31% | Upgrade |
Effective Tax Rate | 24.11% | 24.35% | 22.77% | 24.15% | 19.85% | 18.56% | Upgrade |
Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.